Scarica l'app Stockscreener
1.951
3.50%
-0.059
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché FBIO Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.01
Aprire:
$1.95
Volume 24 ore:
165.02K
Relative Volume:
0.82
Capitalizzazione di mercato:
$57.66M
Reddito:
$80.97M
Utile/perdita netta:
$-78.31M
Rapporto P/E:
-0.176
EPS:
-11.0849
Flusso di cassa netto:
$-129.56M
1 W Prestazione:
+3.18%
1M Prestazione:
+2.63%
6M Prestazione:
+10.21%
1 anno Prestazione:
+5.99%
Intervallo 1D:
$1.90
$2.0299
Intervallo di 1 settimana:
$1.81
$2.04
Portata 52W:
$1.325
$2.36
Fortress Biotech Inc Stock (FBIO) Company Profile
Nome
Fortress Biotech Inc
Settore
Industria
Telefono
781-652-4500
Indirizzo
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Confronta FBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
1.95 | 56.77M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
393.63 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.00 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.49 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
645.68 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
303.19 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-03-15 | Ripresa | ROTH MKM | Buy |
| 2022-08-04 | Iniziato | Ladenburg Thalmann | Buy |
| 2020-10-02 | Iniziato | The Benchmark Company | Buy |
| 2019-12-18 | Iniziato | B. Riley FBR | Buy |
| 2018-02-28 | Iniziato | B. Riley FBR, Inc. | Buy |
| 2017-07-11 | Iniziato | Rodman & Renshaw | Buy |
| 2017-03-22 | Iniziato | JMP Securities | Mkt Outperform |
| 2016-10-03 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Fortress Biotech Inc Borsa (FBIO) Ultime notizie
Multi asset correlation models including Fortress Biotech Inc.Portfolio Performance Report & Daily Volume Surge Trade Alerts - Newser
Fortress Biotech Inc.’s volatility index tracking explainedBond Market & Weekly Chart Analysis and Trade Guides - Newser
Visualizing Fortress Biotech Inc. stock with heatmapsTrade Performance Summary & Growth Focused Stock Pick Reports - Newser
Fortress Biotech Inc. stock trend outlook and recovery pathMarket Trend Summary & Growth Focused Entry Reports - Newser
Will Fortress Biotech Inc. price bounce be sustainableJuly 2025 Momentum & Accurate Trade Setup Notifications - Newser
Using Python tools to backtest Fortress Biotech Inc. strategies [Stock Surge]Trade Opportunity Analysis - Newser
How Fortress Biotech Inc. stock performs during market volatilityWeekly Profit Report & Verified Trade Idea Suggestions - Newser
Statistical indicators supporting Fortress Biotech Inc.’s strengthAI Generated Buy/Sell Signal Forecast - Newser
Key metrics from Fortress Biotech Inc.’s quarterly dataAI-Powered Stock Trend Movement Analysis - Newser
Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights - GlobeNewswire
Strategies to average down on Fortress Biotech Inc.Wealth Accumulation Outlook for Safe Investors - Newser
Chart based exit strategy for Fortress Biotech Inc.AI Screener for Daily Stock Forecast - Newser
Will Fortress Biotech Inc. rebound enough to break evenStrategy Playbook for Risk Controlled Trades - Newser
Should you hold or exit Fortress Biotech Inc. nowDaily Equity Signal Strength Summary Report - Newser
How high can Fortress Biotech Inc. stock goSmart Entry Watchlist with Daily Analysis - Newser
Multi factor analysis applied to Fortress Biotech Inc.Free Technical Entry Strategy for Beginners - Newser
Will Fortress Biotech Inc. stock split in the near futureTechnical Safety Zone Pattern Recognition - Newser
Key External Factors That Drive Fortress Biotech Inc. Stock Price MovementsRapid Trade Forecast Based on Indicators - Newser
Price action breakdown for Fortress Biotech Inc.Chart-Based Entry Confirmation for Beginners - Newser
Tools to assess Fortress Biotech Inc.’s risk profileSwing Trade Signal and Price Prediction - Newser
Fortress Biotech Inc. Ranks High in Smart Money TrackerRisk Controlled Picks With Real Returns Outlined - beatles.ru
Detecting price anomalies in Fortress Biotech Inc. with AIFuture Growth Stock Forecasting Strategy - Newser
How to build a dashboard for Fortress Biotech Inc. stockFree Access to Smart Investment Tips - Newser
Why Fortress Biotech Inc. stock attracts strong analyst attentionFree Weekly Stock Watch With Growth Focus - Newser
Fortress Biotech (FBIO) Expected to Announce Quarterly Earnings on Tuesday - Defense World
Using Python tools to backtest Fortress Biotech Inc. strategiesFundamental + Technical Combined Watchlist - Newser
Fortress Biotech Pref A FBIOP Q2 2025 Earnings Preview Upside Potential from Strategic Partnerships - AInvest
Fortress Biotech FBIO 2025Q2 Earnings Preview Upside Potential on Strategic Partnerships and Revenue Growth - AInvest
Combining price and volume data for Fortress Biotech Inc.Community Picked Stocks with Trade Insights - Newser
Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Journey Medical Corporation to Ring Nasdaq Stock Market Closing Bell on August 11 - GlobeNewswire
Envestnet Asset Management Inc. Buys 28,314 Shares of Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World
Is Fortress Biotech Inc. a candidate for recovery playDaily Pick Forecast with Entry Zones - Newser
FORTRESS BIOTECH INC 9.375% CUM RED PER PREF SER A USD25.00 (FBIOP.US) will release its Earnings Reports after the market closes on August 12th. - 富途牛牛
Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 - GlobeNewswire
Fortress Biotech Inc Azioni (FBIO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Fortress Biotech Inc Azioni (FBIO) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| ROSENWALD LINDSAY A MD | PRESIDENT, CEO & CHAIRMAN |
Sep 23 '24 |
Buy |
1.84 |
763,359 |
1,404,581 |
3,657,264 |
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):